Registry of Lobbyists
Version 3 of 5 (1998-01-02 to 1999-02-02) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
ASTRAZENECA CANADA INC.
1004 MIDDLEGATE ROAD MISSISSAUGA, ON L4Y 1M4 Canada |
| Telephone number: | 905-277-7111 |
| Fax number: | 905-270-3248 |
| Responsible officer name and position during the period of this registration: | MURRAY A. BROWN, EXECUTIVE DIRECTOR, GOVERNMENT AFFAIRS |
| Description of activities: | RESEARCH, DEVELOPMENT, SALES AND MARKETING OF PATENTED HUMAN PHARMACEUTICAL PRODUCTS. |
| The client is a subsidiary of the following parent companies: |
ASTRA SWEDEN
Sweden |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Agriculture and Agri-Food Canada (AAFC), Canadian International Trade Tribunal (CITT), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, Science and Technology |
| Subject Matter: Particulars: | LOBBYING & ADVOCATING COMPANY POSITIONS ON POLICIES REGULATIONS & STATUTES CONCERNING HEALTH /INTELLECTUAL PROPERTY PROTECTION/ TRADE & EXPORT. PARLIAMENTARY REVIEW C-91 [ DRUG PATENTS] ONGOING DISCUSSIONS OF REGULATIONS WITH HEALTH PROTECTION BRANCH RELATED TO ISSUES AFFECTING MARKET ACCESS. |